Trial intelligence / Profile preview

Co-Spinal Ondansetron in Inguinal Herniorrhaphy

NCT06850740Enrolling by invitation

Sponsor
Suez Canal University
Start
Mar 2025
Primary completion
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of ondansetron in hypotension (2 arms), sponsored by Suez Canal University. Primary endpoint: Total Ephedrine Consumption. Started Mar 2025; status: enrolling by invitation.

02

Drugs

ondansetron
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT06850740.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06850740.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call